Effect of a New HA Filler in Correcting Nasolabial Fold (NCT06574750) | Clinical Trial Compass
CompletedNot Applicable
Effect of a New HA Filler in Correcting Nasolabial Fold
South Korea74 participantsStarted 2021-10-16
Plain-language summary
The investigators aimed to evaluate the efficacy and safety of new HA filler for nasolabial fold correction
Who can participate
Age range30 Years – 65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients who had prominent NLFs with a WSRS score of 3 or 4 on both sides
Exclusion Criteria:
* patients with active facial skin diseases or history of severe allergies, autoimmune disorders, or hypersensitivity to HA or any of the excipients contained in the investigational filler
* participants who had used a local topical preparation (steroid and retinoid) within 2 weeks before the study
* participants who had undergone chemical peeling, laser procedures, or acne treatments within 4 months before the study
* participants who had been injected with other biomaterials, including HA within 6 months before the study.